SCHEMBL14720882

SCHEMBL14720882

CC(O)Cc1ccc(C=C2CCN(C3CCC3)CC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 2/20 0.43
SRD5A1 P18405 1/20 0.38
HRH3 Q9Y5N1 3/20 0.37
MCHR1 Q99705 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CHRM1 P11229 2/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14721010 0.88 SRD5A2 (0.39) SRD5A2SRD5A1HRH3MCHR1ALDH1A1
SCHEMBL14720849 0.85 SRD5A2 (0.38) SRD5A2SRD5A1HRH3MCHR1ALDH1A1
SCHEMBL14723242 0.85 SRD5A2 (0.47) SRD5A2SRD5A1HRH3CHRM1GAA
SCHEMBL14720522 0.83 HRH3 (0.39) SRD5A2HRH3MCHR1CHRM1
SCHEMBL14721067 0.82 SRD5A2 (0.42) SRD5A2SRD5A1HRH3ALDH1A1L3MBTL1
SCHEMBL14721400 0.82 SRD5A2 (0.48) SRD5A2SRD5A1HRH3MCHR1ALDH1A1
SCHEMBL14720815 0.82 SRD5A2 (0.38) SRD5A2SRD5A1HRH3MCHR1ALDH1A1
SCHEMBL14731084 0.82 SRD5A2 (0.36) SRD5A2SRD5A1HRH3ALDH1A1MEN1
SCHEMBL14722438 0.82 HRH3 (0.39) SRD5A2HRH3MCHR1CHRM1
SCHEMBL14720475 0.81 SRD5A2 (0.39) SRD5A2SRD5A1HRH3NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed